Largest Pharmaceutical Manufacturing Companies by Market Cap

Eli Lilly, founded in 1876, was the first company to mass-produce the polio vaccine and commercialize insulin — and it remains one of the most valuable pharmaceutical companies in the world. The pharmaceutical manufacturing sector spans the full value chain from drug discovery and R&D through clinical trials, regulatory approval, and large-scale production, with U.S. drugmakers accounting for roughly half of global biopharma R&D activity.

This category includes both traditional pharma and biotech companies, since many now operate as “biopharma” firms developing a range of therapeutic products. Among the top companies by market capitalization:

• Diabetes & Obesity: Novo Nordisk (founded 1923, headquartered in Bagsværd, Denmark) produces nearly half the world’s insulin and is behind blockbuster GLP-1 drugs Ozempic and Wegovy. Eli Lilly (NYSE: LLY) also leads in diabetes and obesity therapies.
• Oncology: Roche, founded in 1896 in Basel, Switzerland, derives roughly half its pharmaceutical sales from oncology products. Merck & Co. (NYSE: MRK) markets Keytruda, one of the most widely used cancer immunotherapies.
• Immunology: AbbVie (NYSE: ABBV), spun off from Abbott in 2013, anchors its portfolio around treatments like Humira, Skyrizi, and Rinvoq. Bristol-Myers Squibb (NYSE: BMY), formed in 1989, focuses on immunotherapy and autoimmune treatments.
• Vaccines: Sanofi, headquartered in Paris, is the world’s largest vaccine producer, delivering the first injectable polio vaccine. Pfizer (NYSE: PFE), founded in 1849, operates across more than 185 countries.
• Diversified pharma: Johnson & Johnson (NYSE: JNJ), established in 1886, combines pharmaceutical operations in oncology and immunology with medical technology. AstraZeneca (NASDAQ: AZN), based in Cambridge, UK, specializes in oncology, cardiovascular, and metabolic diseases. Novartis (NYSE: NVS), formed from the 1996 merger of Ciba-Geigy and Sandoz, operates in over 150 countries.

Geographically, U.S. companies dominate the top 50 pharmaceutical firms by market capitalization, followed by European companies — particularly from Switzerland, Denmark, France, and the UK. Japan is home to the largest pharma companies in Asia and represents the third-largest pharmaceutical market globally. For a broader view of the sector including medical devices, see our largest healthcare companies page.

Regulated broker Invest now: Buy Stocks & ETFs in just 15 minutes from $50 Your capital is at risk. Free demo account & education

The table below ranks the leading publicly traded pharmaceutical manufacturing companies by market capitalization, with live pricing and valuations updated throughout the trading day.